中国女人和老外的毛片_少妇激情作爱视频_成人无码区免费AⅤ片在线观看_国产freeXXXX性播放_欧美人与性囗牲恔配的起源

首頁(yè) > 產(chǎn)品目錄 > 信號(hào)通路 > Protein Tyrosine Kinase/RTK > Bcr-Abl > Rebastinib (DCC-2036)

Rebastinib (DCC-2036)

ChemLeader 98+%

Rebastinib (DCC-2036)

產(chǎn)品編號(hào):CL2536 CAS No.:1020172-07-9 MDLNo: 分子式:C30H28FN7O3 分子量:553.59
規(guī)格 庫(kù)存 目錄價(jià) 會(huì)員專享價(jià) 數(shù)量
5 mg 3-5days ¥620.00 登錄后可見(jiàn)
- +
10 mg 3-5days ¥1000.00 登錄后可見(jiàn)
- +
25 mg 3-5days ¥1800.00 登錄后可見(jiàn)
- +

化學(xué)品安全說(shuō)明書(MSDS)

下載MSDS
  • 基本信息
  • 相關(guān)文檔
  • 產(chǎn)品詳情
  • 相關(guān)文獻(xiàn)
基本信息
英文名稱 Rebastinib (DCC-2036)
中文名稱Rebastinib (DCC-2036)
CAS號(hào)1020172-07-9
分子式C30H28FN7O3
分子量553.59
外觀White to off-white powder
儲(chǔ)存條件Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).
產(chǎn)品詳情

Rebastinib (formerly also known as DCC-2036), a novel, potent and orally bioavailable small-molecule inhibitor of multiple tyrosine kinases with potential antineoplastic activity, is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50s of 0.8 nM and 4 nM. It also inhibits other kinases such as SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and has low activity towards c-Kit. DCC-2036 inhibits ABL1 through forcing the kinase domains into inhibitor-bound, inactive Type II conformations. In cellular assay, DCC-2036 inhibits the proliferation of Ba/F3 and K562 cells with IC50 values of 5.4nM and 5.5nM, respectively.

相關(guān)文獻(xiàn)
抱歉,暫時(shí)沒(méi)有相關(guān)文獻(xiàn)
相關(guān)產(chǎn)品
抱歉,暫時(shí)沒(méi)有相關(guān)產(chǎn)品
在線客服
小德
021-58180488
小立
021-58180488
在線服務(wù)時(shí)間: 工作日 9:00-18:00